Please provide your email address to receive an email when new articles are posted on . The addition of pembrolizumab to TIL therapy improved response rates among individuals with metastatic ...

Researchers at Moffitt Cancer Center have found that tapping into the body's own immune system and activating a type of immune cell known as B cells, could be the key to boosting the effectiveness of ...

Genome-scale metabolic reconstruction of urinary microbiome: Pathway for personalized medicine. Frequency and impact of a genome-wide homologous recombination deficiency signature (HRDsig+) on the ...

Health Notes is an occasional listing of health happenings around Louisiana. Have something you'd like to share? Contact us at margaret.delaney@theadvocate.com.

Turnstone Biologics is a clinical-stage biotechnology company developing new medicines to treat and cure solid tumors by pioneering a differentiated approach to TIL therapy. Turnstone’s innovative TIL ...

Presentations showcase Turnstone’s novel Selected TIL programs which are designed to selectively expand the most potent tumor-reactive T cells for treatment of solid tumors Data further supports the ...

Tumor-infiltrating lymphocytes (TILs) are immune cells that naturally recognize and penetrate tumors to kill cancer cells, making them a promising approach for treating solid tumors. This potential ...

Iovance Biotherapeutics (NASDAQ:IOVA) gains attention in the Nasdaq Index as biotech sentiment and allocation trends shift.

SAN DIEGO, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a clinical-stage biotechnology company developing a differentiated approach to ...